Biography

Ms. O’Brien has served as a director since February 2021. Ms. O'Brien is President of CFO'Brien Consulting, LLC which she founded in 2018, providing strategic and operational consulting, and flex time chief financial officer services primarily for early-stage biotech companies. Previously she served as Chief Financial Officer of multiple biopharmaceutical companies including Complexa Inc. and Cerecor Inc., and publicly held Cardiokine, Inc., as well as serving as the Chief Financial Officer and Chief Operating Officer of Cervilenz Inc., a privately held medical device company. Further, she was the Controller at Barrier Therapeutics, Inc., and Chief Financial Officer at Infonautics, Inc., both publicly held companies. She began her career as a CPA at public accounting and advisory firms, most recently at PwC. Ms. O’Brien holds the NACD.Directorship Certification (NACD.DC) from the National Association of Corporate Directors. In 2025 Ms. O'Brien earned a course completion certificate from MIT Sloan School of Management in Cybersecurity Governance for the Board of Directors. Ms. O’Brien received her B.A. in Accounting from Rutgers University and is a Certified Public Accountant — Inactive in the State of New Jersey. The Board believes that Ms. O’Brien’s financial, operational and governance expertise, from a 40-year career in advisory, biopharmaceutical, medical device, and technology companies, qualifies her to serve as a member of our Board.